How Do I Know if My IBS Is Flaring Up?

Here is the honest version of the answer: nobody can hand you a test that says yes, this is a flare. There is no blood marker, no stool marker and no scan that turns an IBS bad patch into a confirmed clinical event. The tests your doctor might run during a bad spell are there to check whether something other than IBS is going on, not to grade the IBS itself.

That leaves one workable method. A flare is defined by comparison with your own normal. Which means the real question is not "what does a flare feel like", because every article will tell you cramping, bloating, urgency and a change in bowel habit, and you already knew that. The real question is "compared with what?"

This guide is about building that "what": a baseline you can actually measure against, a score that puts a number on the episode, and the specific signals that mean what you are having is not an IBS flare at all and needs a doctor rather than a hot water bottle.

The short answer: compare it with your own baseline, not with a symptom list

You are flaring when your usual symptoms are clearly worse than your own recent normal, have stayed that way for more than a day, and are changing decisions you would otherwise make without thinking. That is the whole definition, and every part of it is relative to you.

This is unsatisfying, so it is worth being clear about why it has to be this way. IBS is described in the clinical literature as running a relapsing and remitting course in most people, affecting somewhere between 5% and 10% of otherwise healthy people at any one time (Ford 2020). The Rome Foundation's global study, covering over 73,000 adults across 33 countries, put the worldwide prevalence of IBS by Rome IV criteria at 4.1% (Sperber 2021). The condition is common and it waxes and wanes. But "waxes and wanes" is not a definition of a flare, and no diagnostic framework has ever supplied one.

So the medical system does not have a flare threshold to give you. You have to set your own. The good news is that setting one is not hard, and once you have it, several questions that felt unanswerable become answerable in about thirty seconds.

Why there is no such thing as a lab-confirmed IBS flare

Inflammatory bowel disease has activity indices, faecal calprotectin and endoscopic scoring. IBS has none of that, by design, because IBS is not defined by a lesion or by inflammation.

The Rome criteria define IBS by symptom pattern: recurrent abdominal pain or discomfort associated with defecation, with a change in stool frequency, or with a change in stool form (Lacy 2016). The 2026 revision, Rome V, kept that structure and reorganised bowel disorders into six categories (Corsetti 2026). The Rome process itself is explicit that these are disorders of gut-brain interaction, classified by symptoms because no reliable structural or biochemical marker separates them from health (Drossman 2026).

That absence is genuinely frustrating and it is a recurring theme in patient communities. A long and heavily upvoted thread in r/ibs argued that IBS functions as a name for the unknown, and that once the basic tests come back normal, the system stops looking (r/ibs thread). The frustration is legitimate. It is also worth separating from the practical question in front of you, because the absence of a biomarker does not mean the absence of a method.

There is one detail in Rome V worth knowing, because it changes how you should think about episodes. Rome V specifies that abdominal pain in IBS should not be continuous. In a UK analysis of 1,275 people who said they had IBS, 78% met Rome III criteria, 59% met Rome IV and 70% met Rome V; among those who met Rome III but not Rome V, the overwhelming majority reported continuous abdominal pain (Staller 2026). In other words, the current definition of IBS assumes the symptoms come in episodes. The criteria expect flares. They just never say where one begins.

What actually counts as a flare: three questions

Ask these three in order. Two out of three is a bad patch. Three out of three is a flare.

1. Is it clearly above my baseline, not just above a good day? Everyone has quiet weeks. If your normal is two or three uncomfortable mornings a week and this week has four, that is inside your usual range. If your normal is two and this week is every single day with pain you would rate several points higher, that is outside it.

2. Has it outlasted one full day and one night's sleep? This is the single most useful filter, and it is the one most people skip. A single evening of cramping after a meal out is a reaction. Something that is still there when you wake up, and still there the following evening, is behaving differently.

3. Is it changing what I do? Cancelled plans, a day off, planning a journey around toilets, eating nothing before an event. This is the dimension clinicians care about most and the one patients most often leave out of their description.

That third one has evidence behind it. When researchers asked people with IBS to rate multiple dimensions of their pain, intensity, frequency, constancy and predictability were each strongly and independently associated with overall illness severity, while simply naming pain as the most bothersome symptom was not enough to classify how ill someone was (Spiegel 2010). Unpredictability is not a side effect of severity. It is part of it.

There is a related point hidden in that finding. Defining your own flare threshold reduces unpredictability directly, because you replace a vague sense of dread with a rule. That is a small but real gain on a dimension that independently drives how bad the condition feels.

Put a number on it: the one score your clinician will recognise

If you want one measurable answer to "am I flaring", use the IBS Severity Scoring System, usually written IBS-SSS. It is the instrument most IBS trials use, so your gastroenterologist will recognise it immediately.

It asks five questions, scored to a maximum of 500 in total: whether you currently have abdominal pain and how severe, how many days in the last ten you had pain, how severe abdominal distension is, how satisfied you are with your bowel habit, and how much IBS interferes with your life. In the original validation across 141 patients and 40 healthy controls, scores of 75 to 175 indicated mild, 175 to 300 moderate and over 300 severe disease. Controls scored below 75, and patients in that range can be considered in remission. Repeated within 24 hours the score was highly reproducible, and a change of 50 points reliably indicated real improvement (Francis 1997).

That 50 point figure is the practical bit. It gives you a defensible personal rule:

My baseline IBS-SSS is around 150. A flare is a week where it sits above 200.

Now "am I flaring" has an answer that does not depend on mood, and "is this getting better" has an answer that does not depend on hoping.

You cannot spot a flare without a baseline, so build one first

Two weeks of ordinary logging is enough. The trick is that it has to include the boring days, because the boring days are the baseline, and the boring days are the ones nobody records.

Capture four things, no more:

At the end of two weeks, write down four numbers: your median Bristol type, your typical bowel movements per day, your usual worst pain score, and the number of days in a fortnight you would call bad. That short paragraph is your baseline. It is also, not coincidentally, close to what a gastroenterologist wants to hear in the first minute of an appointment, which our guide to explaining IBS to a doctor goes into properly.

Flare, bad day, or something else entirely

The right-hand column is the one that matters most, and it deserves a section of its own further down.

The early signs people notice before a flare arrives

There is no published early-warning score for IBS. What exists is a consistent set of things people describe noticing in the day or two before things get bad, and a plausible mechanism for most of them.

The most commonly reported ones are increased gut noise and gas without a change in diet, a shift in Bristol type by one or two points in either direction, waking a little earlier with a heavy or uneasy abdomen, and a stretch of poor sleep. Some people describe a general edginess or low mood arriving first.

Two of those have direct evidence. In a study using the experience sampling method, where 80 people with IBS answered prompts ten times a day for a week alongside wrist actigraphy, poor subjective sleep quality predicted next-day abdominal pain and lower gut symptoms, but symptoms did not predict subsequent sleep. Notably, objective actigraphy measures did not predict next-day symptoms, which suggests it is the perception of a bad night that matters (Topan 2024). An earlier study of 24 women with IBS, tracked across a full menstrual cycle with diaries and actigraphy, found much the same directionality: poorer self-reported sleep quality predicted higher next-day abdominal pain, anxiety and fatigue, and the reverse relationship was largely absent (Buchanan 2014).

So if you want one early-warning signal to log, log last night's sleep. It is cheap, it takes five seconds, and it is one of the few next-day predictors with prospective data behind it.

Why a flare can start with no trigger at all

This is the question behind one of the most upvoted flare threads in r/ibs, where someone described a week of severe pain, nausea and diarrhoea while eating carefully, after weeks of eating known trigger foods with no consequence at all. Dozens of replies said the same thing in different words: nothing is ever consistent (r/ibs thread).

There are at least four reasons the same food gives different answers on different days.

Your threshold moves. In an analysis of 407 patients who all underwent colonic transit measurement, rectal barostat testing and psychological assessment, rectal allodynia was present in 36%, hyperalgesia in 22%, accelerated transit in 18% and anxiety in 52%. As the number of these abnormalities stacked up, symptom severity rose in a stepwise fashion and quality of life fell (Simren 2019). These factors are not fixed from week to week. When more of them line up, the same meal lands harder.

Stress and symptoms move together rather than one causing the other. Over 200 treatment-seeking patients kept four weeks of daily prospective stress and symptom measures. The data fitted a model of strong concurrent effects in both directions better than a model where this week's stress caused next week's symptoms; there were no statistically significant independent pathways from stress in one week to gut symptoms in the following weeks (Blanchard 2008). This matters for your log: expecting a clean one-week lag from a stressful event to a flare will make you dismiss a relationship that is real but simultaneous.

Sleep, as above. (Topan 2024)

Your gut may have been changed by an infection you have half-forgotten. A meta-analysis of 47 studies and over 28,000 people found that 14.5% of people developed IBS after an episode of acute gastroenteritis, with more than fourfold higher odds than unexposed controls, and IBS persisting in 39.8% of those followed beyond five years (Porcari 2024). An earlier meta-analysis of 45 studies put the odds of IBS at around four times higher in the year after infectious enteritis (Klem 2017). Even after a Clostridioides difficile infection, a pooled analysis found IBS developing in roughly one in five people (Saha 2022).

If your flares genuinely do not track food, that is information, not a failure of tracking. Our companion piece on why IBS comes and goes goes deeper into the non-food drivers, and how long after eating IBS flares covers the timing windows that make food reactions hard to spot in the first place.

How long does an IBS flare last?

Honest answer: nobody has published a figure, because nobody has agreed a definition to measure. Any article giving you a confident average is making it up.

What does exist is lived experience and a long-run view of the condition. In r/ibs threads asking exactly this, the replies cluster around one to five days, with plenty of people reporting a week or two and a few describing episodes of a month (r/ibs thread). One detail from that thread is worth pulling out, because it is a question rather than an answer. The original poster asked whether "still not feeling normal" is the right way to interpret a flare.

It is not, and this is a common and painful confusion. If you define a flare as any time you do not feel entirely well, then for many people with IBS the flare never ends, and the concept stops doing any work. A flare is a rise above your baseline. Your baseline may itself include daily symptoms. Those are two separate problems and they have different answers: a flare is something to ride out and learn from, while a baseline that is never acceptable is something to take back to a clinician and treat.

The longer view is genuinely reassuring on one point. In a 12 year population-based study following 1,365 residents of Olmsted County, the prevalence of IBS stayed broadly stable, but the turnover in who had symptoms was high. Among people with symptoms at the start, roughly 20% had the same symptoms at follow-up, 40% had no symptoms, and 40% had different symptoms (Halder 2007). Symptoms moving around over the years is the norm, not a sign that something is being missed.

The exhaustion afterwards is real and it is documented

One of the most consistently under-discussed parts of a flare is what happens the day after. A thread in r/ibs asking whether anyone else gets sleepy after an attack drew a long run of replies describing needing to sleep afterwards, a day or two of feeling drained, and comparisons to the aftermath of a panic attack (r/ibs thread).

This is not an obscure phenomenon. A meta-analysis pooling 74 datasets across 16,689 participants found fatigue in about 54.5% of people with IBS, compared with 49.8% in Crohn's disease and 43.6% in ulcerative colitis, with moderate to severe fatigue also most common in IBS (Kim 2024). Fatigue in IBS is at least as common as fatigue in inflammatory bowel disease.

Two practical consequences. First, if you build a flare plan, build the recovery day into it rather than assuming you bounce back the moment the pain stops. Second, log fatigue as its own line. Several people in that thread described the exhaustion, not the gut symptoms, as the part that actually cost them a working day.

When it is not an IBS flare at all

This is the section that matters more than all the rest, and it comes down to one rule: pattern change, not intensity. A louder version of your usual symptoms is most likely a flare. Something genuinely new, or a shift in your baseline that does not go back, is not, and deserves an appointment.

The reason to take that seriously is that treatable conditions do hide behind an IBS label. A systematic review and meta-analysis of consecutive patients meeting IBS criteria in secondary care estimated a pooled prevalence of bile acid diarrhoea of 41% across seven studies, microscopic colitis of 3% across 17 studies and 5,068 patients, and pancreatic exocrine insufficiency of about 4.6% (Poon 2022). Breath-test based estimates in the same review were much higher but are far less reliable as evidence, and the authors note all rates came from secondary care populations, so they are higher than you would expect in the community. An earlier meta-analysis using SeHCAT testing, a more specific method, put bile acid malabsorption in IBS-D at a pooled 28.1% (Slattery 2015).

Coeliac disease is the other classic. A meta-analysis of 36 studies and 15,256 people found roughly four and a half times the odds of biopsy-proven coeliac disease among people meeting IBS criteria compared with controls, though the effect was not seen in North American studies specifically (Irvine 2017). A more recent analysis of 29 studies and 7,209 people with Rome III or Rome IV IBS found pooled coeliac seroprevalence of 6% and biopsy-proven coeliac disease of 2%, and concluded that a positive diagnosis of IBS should not be made without excluding it (Shiha 2025). If you are considering cutting out gluten, ask about testing first, because removing it beforehand makes the tests unreliable.

Both the American College of Gastroenterology and the British Society of Gastroenterology reflect this in their guidance. ACG suggests coeliac serology and faecal calprotectin in people with suspected IBS and diarrhoea, alongside a positive diagnostic strategy rather than a strategy of exclusion (Lacy 2021); the BSG guideline takes a similar line (Vasant 2021). NICE recommends a full blood count, inflammatory markers and coeliac antibody testing in people who meet the criteria, and explicitly says colonoscopy, thyroid function tests, faecal occult blood and hydrogen breath tests are not needed to confirm the diagnosis (NICE CG61).

It is worth knowing that fewer up-front tests is a deliberate, evidence-backed choice rather than a fob-off. A Danish randomised trial compared a positive diagnostic strategy against extensive exclusion testing in primary care; five years later, registry follow-up found no coeliac disease and no gastrointestinal or gynaecological cancers in either group, and the positive strategy had saved endoscopies overall (Engsbro 2021). The flip side is that your description of a pattern change now carries more weight than it used to, so it has to be specific.

Red flags: see a doctor promptly

These change the plan, and they are worth saying out loud early in any appointment rather than saving until the end.

• Blood in your stool, or bleeding from the rectum
• Unintended, unexplained weight loss
• Symptoms that consistently wake you from sleep, particularly night-time diarrhoea
• Fever alongside gut symptoms
• New anaemia, or feeling unusually tired and breathless
• A change in bowel habit to looser or more frequent stools that persists past about six weeks in someone over 60, or a first presentation of this kind after about 50
• A family history of bowel or ovarian cancer, coeliac disease or inflammatory bowel disease
• An abdominal or rectal mass

NICE lists these red flag indicators as prompting referral and further investigation, and says the emergence of any of them during follow-up should prompt further investigation too (NICE CG61).

It also helps to know how these perform, because fear around them is often out of proportion. In a multicentre study of 730 people with suspected IBS who all had colonoscopy, alarm symptoms were present in 75.3% but organic disease was found in only 10.4%; the features with the highest positive predictive value were anaemia at 22.9%, faecal occult blood at 19.4% and unintended weight loss at 16.5% (Yang 2022). In an earlier Australian study, symptom onset at age 50 or over roughly doubled the odds of organic lower gut disease, as did blood on the paper (Hammer 2004).

One Canadian series is worth adding for balance. Among 559 secondary care patients meeting Rome III criteria for IBS, organic disease was found at colonoscopy in 27.7% of those with at least one alarm feature and 15.4% of those with none; in the latter group Crohn's disease was the commonest finding at 7.4%, then coeliac disease at 2.9% and microscopic colitis at 2.2%. Constipation-predominant IBS was considerably less likely to turn up organic disease than the diarrhoea or mixed subtypes (Patel 2015). That was a selected referral population, so it overstates the risk for most people, but it makes the point that a pattern change in IBS-D deserves more curiosity than the same change in IBS-C.

A worked example: two weeks of logs, one honest answer

Here is how this plays out in practice, using a composite case built from the patterns above rather than a real person.

Someone with IBS-D logs a baseline fortnight in March. Median Bristol type 5, two to three bowel movements a day, worst pain typically 3 out of 10, two bad days in the fortnight, sleep mostly 6 or 7 out of 10. IBS-SSS on the Sunday: 165. Moderate, and stable.

In early May, a bad run starts. Their instinct is to blame a Thai meal two nights before. The log says something else.

Three readings come out of that table. First, this meets all three flare tests: intensity above baseline, more than a day, and it cost a working arrangement and a plan. Second, the IBS-SSS moved from 165 to 285, a change of 120 points, comfortably past the 50 point threshold that indicates a real change (Francis 1997). Third, and most usefully, the deterioration started on the Friday, the night before the meal, and it tracks the sleep column almost exactly. Blaming the Thai food would have removed a food they enjoy and fixed nothing.

Note too that the fatigue outlasted the gut symptoms by a day. That is the pattern the r/ibs thread on post-flare exhaustion describes, and the meta-analytic prevalence of fatigue in IBS supports taking it seriously rather than pushing through (Kim 2024).

If you want a structured way to test a suspected food rather than guessing, our guide to finding out what triggers your IBS walks through running a single challenge you can actually trust.

Why your memory of a flare is worse than the flare

There is a quiet measurement problem sitting underneath all of this, and it affects how bad you think your flares are.

In a multicentre psychometric validation study, 230 people with Rome IV IBS across three European countries completed a real-time symptom app up to ten times a day alongside a conventional end-of-day diary, for seven consecutive days. The two correlated strongly, but end-of-day scores were significantly higher than the real-time average (Bosman 2025). When you summarise a day from the sofa at 10pm, you weight it towards the worst moment.

Two practical implications. Log at the time, not at bedtime, because your evening summary is systematically inflated. And be sceptical of your own memory of "how bad the last one was" when deciding whether the current one counts. A written baseline beats recall precisely because recall has a known direction of error.

This is one of the few places a phone genuinely helps: capture at the moment rather than reconstructing at night. Clairop is built around that, logging meals, symptoms and stool in a few seconds, and it can produce a one-page summary to take to an appointment; you can see how that works on the how it works page. The tool matters much less than the timing, though. A note on your phone at the moment it happens beats a beautiful app filled in from memory.

What is worth doing while you are in one

Nothing here is a treatment recommendation, and none of it should replace advice from your own clinician. But it is reasonable to know what the evidence supports, so you can have a specific conversation rather than a vague one.

A structured low FODMAP trial, done properly. A network meta-analysis of 13 randomised trials and 944 patients ranked a low FODMAP diet first against a habitual diet for global IBS symptoms, and superior to standard dietary advice for bloating or distension (Black 2022). The important caveats come from the authors: most trials were in secondary or tertiary care, and they did not study reintroduction or personalisation. It is a short, structured process with a reintroduction phase, ideally run with a dietitian, and it is not meant to be permanent. If restriction is already causing you anxiety around food, that is worth raising first; our piece on the low FODMAP diet and disordered eating covers that ground.

Brain-gut behavioural treatments. A systematic review and network meta-analysis found several of these, including gut-directed hypnotherapy and cognitive behavioural approaches, had a measurable effect on abdominal pain in IBS (Goodoory 2024). These are mainstream, guideline-recognised options, not a suggestion that the symptoms are imaginary.

Movement, at a modest dose. In a randomised controlled trial of 102 patients, an exercise intervention produced a significantly greater reduction in IBS symptom severity than usual care, with fewer people deteriorating in the exercise group (Johannesson 2011).

Sleep, treated as a symptom rather than an afterthought. Given that subjective sleep quality predicts next-day symptoms and not the reverse (Topan 2024), a persistently bad sleep pattern is worth raising with a clinician in its own right.

Myths about IBS flares

"A flare means inflammation." It does not. IBS is not defined by inflammation, and normal inflammatory markers during a bad spell do not mean you are imagining it. They mean the mechanism is something else, most likely some combination of visceral sensitivity, motility and gut-brain signalling (Simren 2019).

"If I can't find the food, I'm not tracking properly." Frequently the food is not the answer. Sleep, stress, hormones and the residue of a past infection are all documented influences, and several of them are invisible in a food-only diary.

"A long flare means my IBS is getting worse." Long-run population data show high turnover in symptoms with stable overall prevalence (Halder 2007). One bad month is weak evidence about your trajectory. Six months of scores is much stronger.

"Normal tests mean nothing is wrong." A normal calprotectin is a meaningful, specific piece of information: it makes IBD very unlikely (Dajti 2023). It says nothing about whether your symptoms are real.

"Everyone with IBS has flares." Not so. Plenty of people describe continuous symptoms with no episodic structure at all, a distinction that shows up clearly in community threads and that Rome V now handles explicitly, since continuous abdominal pain sits outside the IBS definition (Corsetti 2026, Staller 2026). If your pain never lets up, that is worth raising, because the label may not be the right one.

"There's no point logging, it's random." Randomness is a finding, not a dead end. If eight weeks of scores show no relationship to food but a clear relationship to sleep, you have learned something that changes what you do.

When to see a doctor

Book an appointment, without waiting for the flare to end, if:

• Any red flag from the list above is present. See a doctor promptly for blood, unintended weight loss, fever, night-time diarrhoea or new anaemia.
• Your baseline has shifted and stayed shifted for more than about six weeks.
• Flares are getting longer, more frequent, or closer together across several months.
• A symptom is new in kind rather than louder in degree.
• You have never had the basic tests. Ask specifically about coeliac serology and faecal calprotectin, which both ACG and NICE support in the right circumstances (Lacy 2021, NICE CG61).
• Food restriction is expanding and your safe list is shrinking.
• Your baseline itself is not acceptable to you. A flare is something to ride out; a permanently bad normal is something to treat.

Take your numbers with you. Your baseline paragraph, your IBS-SSS trend and the dates of your last few flares will do more in ten minutes than any description of how awful it has been. Our guide to preparing for a GI appointment covers how to lay that out so it gets read.

And if the answer to "am I flaring" turns out to be "I genuinely cannot tell, because I have no idea what my normal is", that is not a failure. It is the most common starting point there is, and two weeks of dull logging fixes it.